Taoren Honghua Jian improves ferroptosis-mediated myocardial damage following myocardial infarction via Nrf2-dependent enhancement of GPX4/FSP1
TRHHJ inhibits cardiomyocyte ferroptosis and improves myocardial damage after MI through activation of Nrf2 signaling.
Authors
- Guoyong Zhang (ORCID: https://orcid.org/0000-0002-3579-0052)
- Tong Xu
- Yaobo Wu
- Xin Han (ORCID: https://orcid.org/0000-0002-1725-7940)
- Mingjie Pang (ORCID: https://orcid.org/0000-0002-5473-2544)
- Lingpeng Xie
- Wenlong Wang (ORCID: https://orcid.org/0000-0001-8355-3863)
- Bin Liu (ORCID: https://orcid.org/0000-0003-2184-4723)
- Dong Wang (ORCID: https://orcid.org/0000-0002-7379-357X)
- Yingchun Zhou (ORCID: https://orcid.org/0000-0003-2623-0472)
- Yan Peng
- Zhixin Wang (ORCID: https://orcid.org/0000-0003-2350-735X)
- Honglin Xu (ORCID: https://orcid.org/0000-0003-4554-862X)
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Shandong University of Aeronautics (CN)
- Yanbian University (CN)
- Second Affiliated Hospital of Guangzhou Medical University (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
- Dongguan People’s Hospital (CN)
- TCM-Intigrated Cancer Center of Southern Medical University (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Pharmacy and Pharmacology
- Published
- 2025-08-11
- DOI
- https://doi.org/10.1093/jpp/rgaf075
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00